| Filed On | Filing |
|---|---|
| 10 Mar 2023 |
8-K/A: Results of Operations and Financial Condition
— Announced preclinical data providing further proof-of-concept for Prime Editing’s ability to achieve restoration of genetic function, as well as new preliminary safety analyses demonstrating no detected off-target activity — |
Loading...
